Anzeige
Mehr »
Donnerstag, 14.08.2025 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JPJ1 | ISIN: US81728J1097 | Ticker-Symbol: 5TX
Tradegate
13.08.25 | 16:16
2,900 Euro
-0,68 % -0,020
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SENSUS HEALTHCARE INC Chart 1 Jahr
5-Tage-Chart
SENSUS HEALTHCARE INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,8602,96013.08.
2,8402,98013.08.

Aktuelle News zur SENSUS HEALTHCARE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DiSensus Healthcare, Inc. - 10-Q, Quarterly Report1
FrSensus Healthcare outlines global expansion and regulatory milestones amid reimbursement uncertainty11
07.08.Sensus Healthcare GAAP EPS of -$0.06 misses by $0.09, revenue of $7.3M misses by $2M6
07.08.Sensus Healthcare, Inc. - 8-K, Current Report1
02.06.Sensus Healthcare, Inc. - 8-K, Current Report4
SENSUS HEALTHCARE Aktie jetzt für 0€ handeln
16.05.Sensus Healthcare anticipates return to profitability in Q2 2025 while pursuing 1,000-unit milestone10
15.05.Sensus Healthcare GAAP EPS of -$0.16 misses by $0.19, revenue of $8.3M beats by $1.07M2
15.05.Sensus Healthcare, Inc. - 8-K, Current Report3
14.05.Exploring Sensus Healthcare's Earnings Expectations4
05.03.Sensus Healthcare, Inc. - 10-K, Annual Report2
04.03.Sensus Healthcare meldet erfolgreiche Studie zur Keloidbehandlung14
05.02.Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results220BOCA RATON, Fla.--(BUSINESS WIRE)--Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments...
► Artikel lesen
18.11.24Sensus Healthcare, Inc.: Sensus Healthcare Reports Third Quarter 2024 Financial Results With Revenues More than Doubling Versus 2023 Third Quarter237Revenues of $8.8 million compare with $3.9 million in the prior-year quarter, adjusted EBITDA (a non-GAAP measure) of $1.6 million compares with negative $1.7 million a year ago Expects to have more...
► Artikel lesen
13 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1